O'CONNOR DANIEL J. (President and CEO) sold 12.7% of their position (50.01K shares) of AMBRX BIOPHARMA, INC. on the open market
Open‑market sale worth $491.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/31/2023ACC: 0000950170-23-056943
DirectorOfficer· President and CEO
Since Oct 2023
-50.01K
Net shares
Net seller
$491.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
50.01K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−50.01K
Price / share
$9.82
Trade value
$491.12K
% of position
12.7%
10/27/2023
392.86K→342.85K
Total
Net shares
−50.01K
Net value
-$491.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/27/2023 | S · Sale | −50.01K | $9.82 | $491.12K | 12.7% | 392.86K | 342.85K |
| Total | −50.01K | -$491.12K | ||||||
Derivative Transactions0
No derivative transactions reported